IRIS
COLECCHIA, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.844
EU - Europa 3.435
NA - Nord America 2.232
SA - Sud America 1.098
AF - Africa 74
OC - Oceania 4
Totale 10.687
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.121
US - Stati Uniti d'America 2.085
SG - Singapore 1.298
CN - Cina 1.229
BR - Brasile 917
HK - Hong Kong 595
IT - Italia 372
VN - Vietnam 358
SE - Svezia 334
FR - Francia 178
DE - Germania 123
BD - Bangladesh 85
GB - Regno Unito 71
AR - Argentina 64
CA - Canada 63
IN - India 61
FI - Finlandia 57
MX - Messico 50
EC - Ecuador 43
AT - Austria 41
IQ - Iraq 34
ID - Indonesia 33
ES - Italia 26
PL - Polonia 26
ZA - Sudafrica 25
TR - Turchia 24
JP - Giappone 21
CO - Colombia 20
NL - Olanda 20
VE - Venezuela 17
PK - Pakistan 14
UZ - Uzbekistan 14
SA - Arabia Saudita 11
TN - Tunisia 11
UA - Ucraina 11
CL - Cile 10
JO - Giordania 10
PY - Paraguay 10
KE - Kenya 9
PE - Perù 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
IE - Irlanda 8
LT - Lituania 7
MA - Marocco 7
MY - Malesia 7
AL - Albania 6
CR - Costa Rica 6
NI - Nicaragua 6
NP - Nepal 6
PT - Portogallo 6
SN - Senegal 6
EG - Egitto 5
JM - Giamaica 5
PH - Filippine 5
UY - Uruguay 5
BG - Bulgaria 4
KZ - Kazakistan 4
PA - Panama 4
AU - Australia 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
KR - Corea 3
OM - Oman 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
LB - Libano 2
LV - Lettonia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
NG - Nigeria 1
NR - Nauru 1
QA - Qatar 1
SY - Repubblica araba siriana 1
Totale 10.685
Salva come PNG Salva come JPEG
Città #
Hong Kong 593
Singapore 570
Moscow 504
Dallas 290
Shanghai 290
San Jose 283
Ashburn 263
Hefei 180
Lauterbourg 153
Ho Chi Minh City 149
Lawrence 149
Princeton 149
Beijing 141
New York 126
Milan 111
São Paulo 75
Hanoi 68
Los Angeles 68
Boardman 45
Rio de Janeiro 45
Helsinki 39
Nuremberg 39
Santa Clara 34
Guangzhou 28
Rome 26
Brasília 25
Porto Alegre 21
Orem 20
Belo Horizonte 19
Warsaw 19
Chennai 18
Atlanta 17
Da Nang 17
Montreal 17
Munich 17
Phoenix 17
Baghdad 16
Frankfurt am Main 16
Curitiba 14
Guayaquil 14
Houston 14
Shenzhen 14
Chicago 13
Denver 13
Dhaka 13
Johannesburg 13
London 13
Manchester 13
Salvador 13
Brooklyn 12
Haiphong 12
Lappeenranta 12
Tashkent 12
Tokyo 12
Council Bluffs 11
Mexico City 11
Naples 11
Quito 11
Turin 11
Vienna 11
Amman 10
Ankara 10
Buffalo 10
Goiânia 10
Osasco 10
Poplar 10
Rozzano 10
Toronto 10
Fortaleza 9
Guarulhos 9
Juiz de Fora 9
Mumbai 9
Stockholm 9
Thái Bình 9
Buenos Aires 8
Caxias do Sul 8
Erbil 8
Jakarta 8
Jiaxing 8
Nairobi 8
Nova Iguaçu 8
Querétaro 8
San Francisco 8
The Dalles 8
Thái Nguyên 8
Tianjin 8
Bogotá 7
Boston 7
Can Tho 7
Cesano Boscone 7
Cluj-Napoca 7
Dublin 7
Genoa 7
Las Vegas 7
New Delhi 7
Piracicaba 7
Washington 7
Amsterdam 6
Betim 6
Biên Hòa 6
Totale 5.255
Salva come PNG Salva come JPEG
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 209
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 160
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 134
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 128
Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis 126
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 126
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 123
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 114
Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia-findings from a multi-centric cross-sectional study 111
A case report of myoid gonadal stromal tumor treated with testis sparing surgery 110
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 109
Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors? 106
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study) 105
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 104
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 103
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 103
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 103
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 100
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 99
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 97
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 96
Atypical pleomorphic epithelioid angiomyolipoma localized to the pelvis: a case report and review of the literature 95
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature. 93
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors 84
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 81
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 81
Immunohistochemistry to Enhance Prognostic Allocation and Guide Decision-Making of Patients With Advanced Urothelial Cancer Receiving First-Line Chemotherapy 80
CD 57 Antigen 80
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty 79
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient 79
Carney triad: case report and molecular analysis of gastric tumor 77
SOX2 and PRAME in the “reprogramming” of seminoma cells 77
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 76
Penile cancer 76
The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer 76
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 75
Benign glomus tumor of the urinary bladder. 75
Carcinoma tiroideo iperfunzionante.Descrizione di un caso. 73
Pathology of testicular and penile neoplasms 72
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma 71
Assessment and reporting of pathological findings of penile specimens 71
Myoid gonadal tumor. Case series, systematic review, and Bayesian analysis 71
Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms 69
Mediastinal germ cell tumors: A narrative review of their traits and aggressiveness features 68
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 68
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System 68
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 67
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 67
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 64
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 64
Dual modulation of MCL-1 and mTOR determines the response to sunitinib 64
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research 64
News in the classification of WHO 2022 testicular tumours 64
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 62
Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management 62
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 62
The Relationship between Characteristics of Inguinal Lymph Nodes and Pelvic Lymph Node Involvement in Penile Squamous Cell Carcinoma: A Single Institution Experience 62
Salivary duct carcinoma of the parotid gland. Report of a case with cytologic and Immunocytochemical findings on fine needle aspiration biopsy 62
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 61
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal 61
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 60
Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study 60
Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testis 60
Detection Rate of Anterior Prostate Cancer in 226 Patients Submitted to Initial and Repeat Transperineal Biopsy 59
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism 59
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists 59
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision 58
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration 58
Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior 58
Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases 57
Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment 57
Prostatic and urothelial metastasis in the same lymph node: a case report 57
Myomelanocytic tumor of the thigh 57
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases 57
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 57
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 56
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 56
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma 56
Integrative transcriptomic analysis reveals distinctive molecular traits and novel subtypes of collecting duct carcinoma 56
Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma? 55
Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node Dissection 55
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure 54
How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey 53
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 53
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors 53
Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder 53
The contributions of Juan Rosai to testicular pathology with personal remembrances 53
Erratum to 'Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations'[European Urology Oncology 2 (2019) 277-285 52
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 52
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 52
Malaric placentas A quantitative study and clinicopathological correlations 52
Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature 51
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution Cohort 51
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference 51
pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy 51
New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification 51
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series 50
Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed 50
Tumors of the testis 50
Response to targeted therapy in urachal adenocarcinoma 50
Totale 7.456
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022100 0 5 2 29 6 2 28 6 3 1 5 13
2022/2023696 348 149 37 4 1 89 11 32 10 6 5 4
2023/2024494 13 27 30 154 21 74 44 35 7 22 15 52
2024/20252.597 394 32 70 44 109 193 279 224 473 444 166 169
2025/20266.992 542 499 561 1.058 432 205 571 438 1.915 357 258 156
Totale 11.019